BlackRock’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $316M | Buy |
|
|||||
|
2025
Q2 | $213M | Sell |
|
|||||
|
2025
Q1 | $257M | Buy |
|
|||||
|
2024
Q4 | $384M | Buy |
|
|||||
|
2024
Q3 | $335M | Buy |
|
|||||
|
2024
Q2 | $279M | Buy |
|
|||||
|
2024
Q1 | $254M | Buy |
|
|||||
|
2023
Q4 | $190M | Buy |
|
|||||
|
2023
Q3 | $144M | Buy |
|
|||||
|
2023
Q2 | $82.9M | Buy |
|
|||||
|
2023
Q1 | $63.5M | Buy |
|
|||||
|
2022
Q4 | $71.7M | Buy |
|
|||||
|
2022
Q3 | $73.7M | Sell |
|
|||||
|
2022
Q2 | $70.7M | Buy |
|
|||||
|
2022
Q1 | $72.4M | Buy |
|
|||||
|
2021
Q4 | $93.1M | Buy |
|
|||||
|
2021
Q3 | $55.1M | Buy |
|
|||||
|
2021
Q2 | $48.9M | Buy |
|
|||||
|
2021
Q1 | $33.1M | Buy |
|
|||||
|
2020
Q4 | $29.8M | Buy |
|
|||||
|
2020
Q3 | $28.2M | Buy |
|
|||||
|
2020
Q2 | $31M | Buy |
|
|||||
|
2020
Q1 | $10.6M | Sell |
|
|||||
|
2019
Q4 | $18.4M | Sell |
|
|||||
|
2019
Q3 | $14.5M | Buy |
|
|||||
|
2019
Q2 | $23.3M | Buy |
|
|||||
|
2019
Q1 | $17.7M | Buy |
|
|||||
|
2018
Q4 | $20.8M | Buy |
|
|||||
|
2018
Q3 | $12M | Buy |
|